68 related articles for article (PubMed ID: 15969859)
1. Benefits of epoetin alfa for cancer patients' quality of life are confirmed after modelling to account for missing data.
Curr Med Res Opin; 2005; 21 Suppl 2():S6-8. PubMed ID: 15969859
[TBL] [Abstract][Full Text] [Related]
2. Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy.
Curr Med Res Opin; 2005; 21 Suppl 2():S9-11. PubMed ID: 15969860
[TBL] [Abstract][Full Text] [Related]
3. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
[TBL] [Abstract][Full Text] [Related]
4. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients.
Curr Med Res Opin; 2005; 21 Suppl 2():S12-5. PubMed ID: 15969861
[TBL] [Abstract][Full Text] [Related]
6. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
7. Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant.
Curr Med Res Opin; 2005; 21 Suppl 2():S3-5. PubMed ID: 15969858
[TBL] [Abstract][Full Text] [Related]
8. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the effects of epoetin alfa treatment on quality of life in anaemic cancer patients.
Curr Med Res Opin; 2005; 21 Suppl 2():S16-8. PubMed ID: 15969862
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.
Chu E; Einhorn LH; Lefebvre P
J Support Oncol; 2006 May; 4(5):243-50. PubMed ID: 16724648
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
[TBL] [Abstract][Full Text] [Related]
14. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
[TBL] [Abstract][Full Text] [Related]
16. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
Lefebvre P; Vekeman F; Sarokhan B; Enny C; Provenzano R; Cremieux PY
Curr Med Res Opin; 2006 Oct; 22(10):1929-37. PubMed ID: 17022852
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Grote T; Yeilding AL; Castillo R; Butler D; Fishkin E; Henry DH; DeLeo M; Fink K; Sullivan DJ
J Clin Oncol; 2005 Dec; 23(36):9377-86. PubMed ID: 16361638
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.
Mystakidou K; Kalaidopoulou O; Katsouda E; Parpa E; Kouskouni E; Chondros C; Tsiatas ML; Vlahos L
Anticancer Res; 2005; 25(5):3495-500. PubMed ID: 16101168
[TBL] [Abstract][Full Text] [Related]
19. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
Leyland-Jones B; Semiglazov V; Pawlicki M; Pienkowski T; Tjulandin S; Manikhas G; Makhson A; Roth A; Dodwell D; Baselga J; Biakhov M; Valuckas K; Voznyi E; Liu X; Vercammen E
J Clin Oncol; 2005 Sep; 23(25):5960-72. PubMed ID: 16087945
[TBL] [Abstract][Full Text] [Related]
20. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Osterborg A; Brandberg Y
Cancer; 2003 Jun; 97(12):3125-6; author reply 3126-7. PubMed ID: 12784351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
